March 03, 2015 6:23 PM ET


Company Overview of BioRelix, Inc.

Company Overview

BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.

5 Science Park at Yale

401 Winchester Avenue

Suite 10

New Haven, CT 06511

United States

Founded in 2005





Key Executives for BioRelix, Inc.

Chief Executive Officer and Director
Co- Founder and Director of Research
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Biosynthema, Inc. United States
MBC Pharma, Inc. United States
Adynxx, Inc United States
Manhattan Drug Company, Inc. United States
Vallinex Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioRelix, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at